
Opinion|Videos|June 25, 2024
Key Takeaways on mBC and eBC
Key opinion leaders (KOLs) provide key takeaways on metastatic breast cancer and early breast cancer, emphasizing the enthusiasm surrounding recent advances in the field and the potential for improved patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- What are your key takeaways on the evolving treatment landscape for metastatic breast cancer and early breast cancer?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
3
Current and Emerging BCMAxCD3 Bispecifics
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5